jakedogman
What can they do? They don't have diddly squat until Fall or later. Anyone else know what other news can come out? HIV I figure for late fall, Cotara I figure for end of year or Q1, Bavi cancer isn't even starting until Fall, Duke won't let PPHM say anything, so what else can they come out with? Maybe some pre clinicals but will that lift the stock 30%?
Speaking of "PPHM" I listened to the conference call again this weekend and heard Lytle refer to Peregrine as "PPHM" twice. Nothing like preparation, huh? He can't even write the word PEREGRINE in his script he writes "PPHM" and is so unprepared in his presentation that he says "PPHM" instead of Peregrine. As much as we all want Wall Street's attention and real money managers and analysts on the calls, if they hear the CFO referring to the company as the call letters of its stock, it's probably a "sell" or a "stay away" as that is just so unprofessional it's unbelievable.